Welcome to LookChem.com Sign In|Join Free

CAS

  • or

172215-92-8

Post Buying Request

172215-92-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

172215-92-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 172215-92-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,2,2,1 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 172215-92:
(8*1)+(7*7)+(6*2)+(5*2)+(4*1)+(3*5)+(2*9)+(1*2)=118
118 % 10 = 8
So 172215-92-8 is a valid CAS Registry Number.

172215-92-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3,4-trichloro-6-nitroaniline

1.2 Other means of identification

Product number -
Other names 2,3,4-Trichlor-6-nitro-anilin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:172215-92-8 SDS

172215-92-8Relevant articles and documents

BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR?) AND PHARMACEUTICAL USES THEREOF

-

Page/Page column 128; 143; 145; 176; 177, (2019/11/19)

The present invention relates to benzimidazole derivatives of formula (I) as inhibitors of retinoid-related orphan receptor gamma (RORγ) protein, pharmaceutical compositions containing the compounds, preparation methods thereof, and the use of the compoun

L-benzimidazole nucleosides

-

, (2008/06/13)

The present invention relates to benzimidazole derivatives and their use in medical therapy particularly for the treatment or prophylaxis of virus infections such as those caused by herpes viruses. The invention also relates to the preparation of the benzimidazole derivatives and pharmaceutical formulations containing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 172215-92-8